Tag: GLP-1 drugs

Market News

2026: Obesity Pills from Novo Nordisk and Eli Lilly Arrive

Imagine swapping weekly injections for a simple daily pill to tackle obesity. In 2026, that's becoming reality with new oral...

16/12/2025

18 views

Read More

Global Markets

Why the Spirits Market Is Facing a Sober Revolution

The holiday season is here, with parties in full swing and festive drinks flowing—or are they? This year, the spirits...

13/12/2025

6 views

Read More

Market News

Fed Cuts Rates Again: Markets Rally on Dovish Signal

The Fed just cut rates for the third time this year—yet Powell says policy still isn’t accommodative. Markets loved it...

10/12/2025

3 views

Read More

Growth Picks

Eli Lilly Stock Soars: Why BofA Sees 22% More Upside

Bank of America just slapped a $1,286 price target on Eli Lilly — that’s 22% higher from here. The reason?...

02/12/2025

12 views

Read More

Growth Picks

Eli Lilly Slashes Zepbound Prices: Bullish for Investors?

Eli Lilly just dropped the cash price of Zepbound vials to $299-$399/month. The stock dipped 1% on the news, but...

01/12/2025

3 views

Read More

Market News

Health Premiums Soar for Small Businesses in 2025

Health premiums for small businesses hit $26K for families in 2025—up massively since 2020. With ACA credits expiring and a...

31/10/2025

9 views

Read More

Market News

Eli Lilly Walmart Zepbound Vials Discount Access

Eli Lilly teams with Walmart for in-store Zepbound vial pickups at hugeAnalyzing prompt- The request involves generating a blog article...

29/10/2025

3 views

Read More

Market News

Novo Shares Tumble on Trump’s Ozempic Price Cut Vow

President Trump's offhand remark about slashing Ozempic prices to $150 sent Novo Nordisk shares plummeting 7% overnight. As negotiations heat...

17/10/2025

3 views

Read More

Market News

Understanding Ozempic Face: Causes and Solutions

Rapid weight loss can leave your face looking older, but why? Discover the truth behind Ozempic face and how to...

30/09/2025

8 views

Read More

Global Companies

Eli Lilly’s $6.5B Texas Plant: Obesity Pill Boom

Eli Lilly's $6.5B Texas plant is set to revolutionize obesity treatment with a new pill. How will it shape the...

23/09/2025

2 views

Read More